100 related articles for article (PubMed ID: 16545382)
21. The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein.
Sunyach C; Jen A; Deng J; Fitzgerald KT; Frobert Y; Grassi J; McCaffrey MW; Morris R
EMBO J; 2003 Jul; 22(14):3591-601. PubMed ID: 12853474
[TBL] [Abstract][Full Text] [Related]
22. Prion protein misfolding.
Kupfer L; Hinrichs W; Groschup MH
Curr Mol Med; 2009 Sep; 9(7):826-35. PubMed ID: 19860662
[TBL] [Abstract][Full Text] [Related]
23. The determinants of stability in the human prion protein: insights into folding and misfolding from the analysis of the change in the stabilization energy distribution in different conditions.
Colacino S; Tiana G; Broglia RA; Colombo G
Proteins; 2006 Mar; 62(3):698-707. PubMed ID: 16432880
[TBL] [Abstract][Full Text] [Related]
24. Prion metal interaction: is prion pathogenesis a cause or a consequence of metal imbalance?
Rana A; Gnaneswari D; Bansal S; Kundu B
Chem Biol Interact; 2009 Oct; 181(3):282-91. PubMed ID: 19660443
[TBL] [Abstract][Full Text] [Related]
25. [Molecular bases of prion diseases].
Rać M; Rać M
Ann Acad Med Stetin; 2006; 52(3):5-13. PubMed ID: 17385343
[TBL] [Abstract][Full Text] [Related]
26. Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives.
Pappalardo G; Milardi D; Magrì A; Attanasio F; Impellizzeri G; La Rosa C; Grasso D; Rizzarelli E
Chemistry; 2007; 13(36):10204-15. PubMed ID: 17902185
[TBL] [Abstract][Full Text] [Related]
27. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
Bertho G; Bouvier G; Hoa GH; Girault JP
Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265
[TBL] [Abstract][Full Text] [Related]
28. Amyloidogenic properties of the prion protein fragment PrP(185-208): comparison with Alzheimer's peptide Abeta(1-28), influence of heparin and cell toxicity.
Cortijo-Arellano M; Ponce J; Durany N; Cladera J
Biochem Biophys Res Commun; 2008 Apr; 368(2):238-42. PubMed ID: 18206983
[TBL] [Abstract][Full Text] [Related]
29. Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann-Sträussler-Scheinker disease peptides in the presence of metal ions.
Ricchelli F; Buggio R; Drago D; Salmona M; Forloni G; Negro A; Tognon G; Zatta P
Biochemistry; 2006 May; 45(21):6724-32. PubMed ID: 16716083
[TBL] [Abstract][Full Text] [Related]
30. Copper induces conformational changes in the N-terminal part of cell-surface PrPC.
Leclerc E; Serban H; Prusiner SB; Burton DR; Williamson RA
Arch Virol; 2006 Nov; 151(11):2103-9. PubMed ID: 16791441
[TBL] [Abstract][Full Text] [Related]
31. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins.
Fernandez-Escamilla AM; Rousseau F; Schymkowitz J; Serrano L
Nat Biotechnol; 2004 Oct; 22(10):1302-6. PubMed ID: 15361882
[TBL] [Abstract][Full Text] [Related]
32. The conversion of helix H2 to beta-sheet is accelerated in the monomer and dimer of the prion protein upon T183A mutation.
Chebaro Y; Derreumaux P
J Phys Chem B; 2009 May; 113(19):6942-8. PubMed ID: 19371053
[TBL] [Abstract][Full Text] [Related]
33. Beta-hairpin folding by a model amyloid peptide in solution and at an interface.
Knecht V
J Phys Chem B; 2008 Aug; 112(31):9476-83. PubMed ID: 18593146
[TBL] [Abstract][Full Text] [Related]
34. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
Nazabal A; Hornemann S; Aguzzi A; Zenobi R
J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
[TBL] [Abstract][Full Text] [Related]
35. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
Leliveld SR; Stitz L; Korth C
Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
[TBL] [Abstract][Full Text] [Related]
36. Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.
Lau AL; Yam AY; Michelitsch MM; Wang X; Gao C; Goodson RJ; Shimizu R; Timoteo G; Hall J; Medina-Selby A; Coit D; McCoin C; Phelps B; Wu P; Hu C; Chien D; Peretz D
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11551-6. PubMed ID: 17601775
[TBL] [Abstract][Full Text] [Related]
37. Peptide NMHRYPNQ of the cellular prion protein (PrP(C)) inhibits aggregation and is a potential key for understanding prion-prion interactions.
Rehders D; Claasen B; Redecke L; Buschke A; Reibe C; Jehmlich N; von Bergen M; Betzel C; Meyer B
J Mol Biol; 2009 Sep; 392(1):198-207. PubMed ID: 19607841
[TBL] [Abstract][Full Text] [Related]
38. Two-rung model of a left-handed beta-helix for prions explains species barrier and strain variation in transmissible spongiform encephalopathies.
Langedijk JP; Fuentes G; Boshuizen R; Bonvin AM
J Mol Biol; 2006 Jul; 360(4):907-20. PubMed ID: 16782127
[TBL] [Abstract][Full Text] [Related]
39. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
[TBL] [Abstract][Full Text] [Related]
40. Can copper binding to the prion protein generate a misfolded form of the protein?
Pushie MJ; Rauk A; Jirik FR; Vogel HJ
Biometals; 2009 Feb; 22(1):159-75. PubMed ID: 19140013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
